Global On-body Injectors Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global On-body Injectors market size was valued at US$ 181 million in 2024 and is forecast to a readjusted size of USD 467 million by 2031 with a CAGR of 14.6% during review period.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
This report is a detailed and comprehensive analysis for global On-body Injectors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global On-body Injectors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global On-body Injectors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global On-body Injectors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global On-body Injectors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for On-body Injectors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global On-body Injectors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include West Pharmaceutical Services, Insulet, Gerresheimer, United Therapeutics, CC Bio, BD, Ypsomed, Enable Injections, Nemera, Stevanato Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Electronic Injectors
Mechanical Injectors
Market segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Major players covered
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales quantity, revenue, and global market share of On-body Injectors from 2020 to 2025.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and On-body Injectors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
This report is a detailed and comprehensive analysis for global On-body Injectors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global On-body Injectors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global On-body Injectors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global On-body Injectors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global On-body Injectors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for On-body Injectors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global On-body Injectors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include West Pharmaceutical Services, Insulet, Gerresheimer, United Therapeutics, CC Bio, BD, Ypsomed, Enable Injections, Nemera, Stevanato Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Electronic Injectors
Mechanical Injectors
Market segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Major players covered
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales quantity, revenue, and global market share of On-body Injectors from 2020 to 2025.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and On-body Injectors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.
Table of Contents
118 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: On-body Injectors by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
